: The germinal center (GC) dark zone (DZ) and light zone represent distinct anatomical regions in lymphoid tissue where B cell proliferation, immunoglobulin diversification, and selection are coordinated. Diffuse large B cell lymphomas (DLBCLs) with DZ-like gene expression profiles exhibit poor outcomes, though the reasons are unclear and are not directly related to proliferation. Physiological DZs exhibit an exclusion of T cells, prompting exploration of whether T cell paucity contributes to DZ-like DLBCL. We used spatial transcriptomic approaches to achieve higher resolution of T cell spatial heterogeneity in the GC and to derive potential pathways that underlie T cell exclusion. We showed that T cell exclusion from the DZ was linked to DNA damage response (DDR) and chromatin compaction molecular features characterizing the spatial DZ signature, and that these programs were independent of activation-induced cytidine deaminase (AID) activity. As ATR is a key regulator of DDR, we tested its role in the T cell inhibitory DZ transcriptional imprint. ATR inhibition reversed not only the DZ transcriptional signature, but also DZ T cell exclusion in DZ-like DLBCL in vitro microfluidic models and in in vivo samples of murine lymphoid tissue. These findings highlight that ATR activity underpins a physiological scenario of immune silencing. ATR inhibition may reverse the immune-silent state and enhance T cell-based immunotherapy in aggressive lymphomas with GC DZ-like characteristics.
Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zone / Cancila, Valeria; Bertolazzi, Giorgio; Chan, Allison S. Y.; Medico, Giovanni; Bastianello, Giulia; Morello, Gaia; Paysan, Daniel; Lai, Clemence; Hong, Liang; Shenoy, Girija; Jaynes, Patrick W.; Schiavoni, Giovanna; Mattei, Fabrizio; Piconese, Silvia; Revuelta, Maria V.; Noto, Francesco; Businaro, Luca; De Ninno, Adele; Cammarata, Ilenia; Pagni, Fabio; Venkatachalapathy, Saradha; Sangaletti, Sabina; Di Napoli, Arianna; Cicio, Giada; Vacca, Davide; Lonardi, Silvia; Lorenzi, Luisa; Ferreri, Andrés J. M.; Belmonte, Beatrice; Liu, Min; Lakshmanan, Manikandan; Ong, Michelle S. N.; Zhang, Biyan; See, Tingyi; Lam, Kong-Peng; Varano, Gabriele; Colombo, Mario P.; Bicciato, Silvio; Inghirami, Giorgio; Cerchietti, Leandro; Ponzoni, Maurilio; Zappasodi, Roberta; Metzger, Evelyn; Beechem, Joseph; Facchetti, Fabio; Foiani, Marco; Casola, Stefano; Jeyasekharan, Anand D.; Tripodo, Claudio. - In: THE JOURNAL OF CLINICAL INVESTIGATION. - ISSN 1558-8238. - 135:18(2025). [10.1172/jci187371]
Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zone
Schiavoni, Giovanna;Mattei, Fabrizio;Piconese, Silvia;Noto, Francesco;De Ninno, Adele;Cammarata, Ilenia;Di Napoli, Arianna;
2025
Abstract
: The germinal center (GC) dark zone (DZ) and light zone represent distinct anatomical regions in lymphoid tissue where B cell proliferation, immunoglobulin diversification, and selection are coordinated. Diffuse large B cell lymphomas (DLBCLs) with DZ-like gene expression profiles exhibit poor outcomes, though the reasons are unclear and are not directly related to proliferation. Physiological DZs exhibit an exclusion of T cells, prompting exploration of whether T cell paucity contributes to DZ-like DLBCL. We used spatial transcriptomic approaches to achieve higher resolution of T cell spatial heterogeneity in the GC and to derive potential pathways that underlie T cell exclusion. We showed that T cell exclusion from the DZ was linked to DNA damage response (DDR) and chromatin compaction molecular features characterizing the spatial DZ signature, and that these programs were independent of activation-induced cytidine deaminase (AID) activity. As ATR is a key regulator of DDR, we tested its role in the T cell inhibitory DZ transcriptional imprint. ATR inhibition reversed not only the DZ transcriptional signature, but also DZ T cell exclusion in DZ-like DLBCL in vitro microfluidic models and in in vivo samples of murine lymphoid tissue. These findings highlight that ATR activity underpins a physiological scenario of immune silencing. ATR inhibition may reverse the immune-silent state and enhance T cell-based immunotherapy in aggressive lymphomas with GC DZ-like characteristics.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


